Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial.
Wester CW, Okezie OA, Thomas AM, Bussmann H, Moyo S, Muzenda T, Makhema J, van Widenfelt E, Musonda R, Novitsky V, Gaolathe T, Ndwapi N, Essex M, Kuritzkes DR, DeGruttola V, Marlink RG. Wester CW, et al. Among authors: musonda r. J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):318-22. doi: 10.1097/QAI.0b013e3181568e3f. J Acquir Immune Defic Syndr. 2007. PMID: 18090299 Clinical Trial.
Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana.
Moyo S, Bussmann H, Mangwendeza P, Dusara P, Gaolathe T, Mine M, Musonda R, van Widenfelt E, Novitsky V, Makhema J, Marlink RG, Essex M, Wester CW. Moyo S, et al. Among authors: musonda r. J Antivir Antiretrovir. 2011 Oct;3(4):45-48. doi: 10.4172/jaa.1000034. Epub 2011 Sep 20. J Antivir Antiretrovir. 2011. PMID: 23087782 Free PMC article.
No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.
Souda S, Gaseitsiwe S, Georgette N, Powis K, Moremedi D, Iketleng T, Leidner J, Moffat C, Ogwu A, Lockman S, Moyo S, Mmalane M, Musonda R, Makhema J, Essex M, Shapiro R. Souda S, et al. Among authors: musonda r. J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):572-7. doi: 10.1097/QAI.0b013e31829308f8. J Acquir Immune Defic Syndr. 2013. PMID: 23542639 Free PMC article. Clinical Trial.
Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.
McDonald B, Moyo S, Gabaitiri L, Gaseitsiwe S, Bussmann H, Koethe JR, Musonda R, Makhema J, Novitsky V, Marlink RG, Wester CW, Essex M. McDonald B, et al. Among authors: musonda r. AIDS Res Hum Retroviruses. 2013 Jul;29(7):993-9. doi: 10.1089/aid.2012.0309. Epub 2013 May 9. AIDS Res Hum Retroviruses. 2013. PMID: 23590237 Free PMC article. Clinical Trial.
Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana.
Novitsky V, Gaolathe T, Mmalane M, Moyo S, Chakalisa U, Yankinda EK, Marukutira T, Holme MP, Sekoto T, Gaseitsiwe S, Musonda R, van Widenfelt E, Powis KM, Khan N, Dryden-Peterson S, Bennett K, Wirth KE, Tchetgen ET, Bachanas P, Mills LA, Lebelonyane R, El-Halabi S, Makhema J, Lockman S, Essex M. Novitsky V, et al. Among authors: musonda r. J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):557-565. doi: 10.1097/QAI.0000000000001715. J Acquir Immune Defic Syndr. 2018. PMID: 29771781 Free PMC article.
Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
Bussmann H, Wester CW, Thomas A, Novitsky V, Okezie R, Muzenda T, Gaolathe T, Ndwapi N, Mawoko N, Widenfelt E, Moyo S, Musonda R, Mine M, Makhema J, Moffat H, Essex M, Degruttola V, Marlink RG. Bussmann H, et al. Among authors: musonda r. J Acquir Immune Defic Syndr. 2009 May 1;51(1):37-46. doi: 10.1097/QAI.0b013e31819ff102. J Acquir Immune Defic Syndr. 2009. PMID: 19282782 Free PMC article. Clinical Trial.
Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.
Novitsky V, Woldegabriel E, Kebaabetswe L, Rossenkhan R, Mlotshwa B, Bonney C, Finucane M, Musonda R, Moyo S, Wester C, van Widenfelt E, Makhema J, Lagakos S, Essex M. Novitsky V, et al. Among authors: musonda r. J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):65-76. doi: 10.1097/QAI.0b013e3181900141. J Acquir Immune Defic Syndr. 2009. PMID: 19295336 Free PMC article.
Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.
Diphoko T, Gaseitsiwe S, Kasvosve I, Moyo S, Okatch H, Musonda R, Wainberg M, Makhema J, Marlink R, Novitsky V, Essex M. Diphoko T, et al. Among authors: musonda r. AIDS Res Hum Retroviruses. 2018 Aug;34(8):667-671. doi: 10.1089/AID.2017.0135. Epub 2018 Jun 12. AIDS Res Hum Retroviruses. 2018. PMID: 29732907 Free PMC article.
Infant feeding practices were not associated with breast milk HIV-1 RNA levels in a randomized clinical trial in Botswana.
Rossenkhan R, Novitsky V, Sebunya TK, Leidner J, Hagan JE, Moyo S, Smeaton L, Lockman S, Musonda R, Ndung'u T, Gaseitsiwe S, Thior I, Mmalane M, Makhema J, Essex M, Shapiro R. Rossenkhan R, et al. Among authors: musonda r. AIDS Behav. 2012 Jul;16(5):1260-4. doi: 10.1007/s10461-011-0035-7. AIDS Behav. 2012. PMID: 21901486 Free PMC article. Clinical Trial.
Immunohaematological reference values for HIV-negative healthy adults in Botswana.
Mine M, Moyo S, Stevens P, Michael K, Novitsky V, Makhaola K, Asmelash A, Molefhabangwe S, Woldegabriel E, Mothowaeng G, Maruta T, Kamhukamwe C, Mangwendeza PM, Holmes-Pretorius M, Mtoni I, Motswaledi M, Musonda R, Ndwapi N, Makhema J, Marlink R, Seipone K, Gaolathe T, Essex M. Mine M, et al. Among authors: musonda r. Afr J Lab Med. 2012;1(1):5. doi: 10.4102/ajlm.v1i1.5. Afr J Lab Med. 2012. PMID: 23772402 Free PMC article.
106 results